Literature DB >> 22492291

Low frequency of type-I and type-II aberrations in myeloid leukemia of Down syndrome, underscoring the unique entity of this disease.

Marjolein Blink, Marry M van den Heuvel-Eibrink, Valerie de Haas, Jan-Henning Klusmann, Henrik Hasle, C Michel Zwaan.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22492291      PMCID： PMC3347681          DOI： 10.3324/haematol.2011.057505

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  No prognostic impact of the WT1 gene single nucleotide polymorphism rs16754 in pediatric acute myeloid leukemia.

Authors:  Iris H I M Hollink; Marry M van den Heuvel-Eibrink; Martin Zimmermann; Brian V Balgobind; Susan T C J M Arentsen-Peters; Marielle Alders; Andre Willasch; Gert-Jan J L Kaspers; Jan Trka; Andre Baruchel; Ursula Creutzig; Rob Pieters; Dirk Reinhardt; C Michel Zwaan
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

2.  WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology group.

Authors:  Phoenix A Ho; Julia Kuhn; Robert B Gerbing; Jessica A Pollard; Rong Zeng; Kristen L Miller; Nyla A Heerema; Susana C Raimondi; Betsy A Hirsch; Janet L Franklin; Beverly Lange; Alan S Gamis; Todd A Alonzo; Soheil Meshinchi
Journal:  J Clin Oncol       Date:  2010-12-28       Impact factor: 44.544

3.  NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.

Authors:  Iris H I M Hollink; Marry M van den Heuvel-Eibrink; Susan T C J M Arentsen-Peters; Marta Pratcorona; Saman Abbas; Jenny E Kuipers; Janneke F van Galen; H Berna Beverloo; Edwin Sonneveld; Gert-Jan J L Kaspers; Jan Trka; Andre Baruchel; Martin Zimmermann; Ursula Creutzig; Dirk Reinhardt; Rob Pieters; Peter J M Valk; C Michel Zwaan
Journal:  Blood       Date:  2011-08-02       Impact factor: 22.113

4.  Low frequency of DNMT3A mutations in pediatric AML, and the identification of the OCI-AML3 cell line as an in vitro model.

Authors:  I H I M Hollink; Q Feng; A A Danen-van Oorschot; S T C J M Arentsen-Peters; L J Verboon; P Zhang; V de Haas; D Reinhardt; U Creutzig; J Trka; R Pieters; M M van den Heuvel-Eibrink; J Wang; C M Zwaan
Journal:  Leukemia       Date:  2011-08-12       Impact factor: 11.528

5.  WT1 gene expression in children with Down syndrome and transient myeloproliferative disorder.

Authors:  Henrik Hasle; Bendik Lund; Charlotte Guldborg Nyvold; Peter Hokland; Mette Østergaard
Journal:  Leuk Res       Date:  2005-10-19       Impact factor: 3.156

6.  Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia.

Authors:  Brian V Balgobind; Iris H I M Hollink; Susan T C J M Arentsen-Peters; Martin Zimmermann; Jochen Harbott; H Berna Beverloo; Anne R M von Bergh; Jacqueline Cloos; Gertjan J L Kaspers; Valerie de Haas; Zuzana Zemanova; Jan Stary; Jean-Michel Cayuela; Andre Baruchel; Ursula Creutzig; Dirk Reinhardt; Rob Pieters; C Michel Zwaan; Marry M van den Heuvel-Eibrink
Journal:  Haematologica       Date:  2011-07-26       Impact factor: 9.941

Review 7.  Pattern of malignant disorders in individuals with Down's syndrome.

Authors:  H Hasle
Journal:  Lancet Oncol       Date:  2001-07       Impact factor: 41.316

Review 8.  Origins of leukaemia in children with Down syndrome.

Authors:  Johann K Hitzler; Alvin Zipursky
Journal:  Nat Rev Cancer       Date:  2005-01       Impact factor: 60.716

Review 9.  The roles of FLT3 in hematopoiesis and leukemia.

Authors:  D Gary Gilliland; James D Griffin
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

10.  Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study.

Authors:  A M Willasch; B Gruhn; T Coliva; M Kalinova; G Schneider; H Kreyenberg; D Steinbach; G Weber; I H I M Hollink; C M Zwaan; A Biondi; V H J van der Velden; D Reinhardt; G Cazzaniga; P Bader; J Trka
Journal:  Leukemia       Date:  2009-03-26       Impact factor: 11.528
View more
  1 in total

1.  Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international study.

Authors:  Marjolein Blink; Martin Zimmermann; Christine von Neuhoff; Dirk Reinhardt; Valerie de Haas; Henrik Hasle; Maureen M O'Brien; Batia Stark; Julie Tandonnet; Andrea Pession; Katerina Tousovska; Daniel K L Cheuk; Kazuko Kudo; Takashi Taga; Jeffrey E Rubnitz; Iren Haltrich; Walentyna Balwierz; Rob Pieters; Erik Forestier; Bertil Johansson; Marry M van den Heuvel-Eibrink; C Michel Zwaan
Journal:  Haematologica       Date:  2013-08-09       Impact factor: 9.941
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.